For younger people in the United States, a medical presentation with self-harm is a strong predictor of a subsequent new diagnosis of a bipolar or psychotic disorder, according to study findings ...

VoiceThread Recording Submission Deadline (for those accepted for Virtual and In-person Posters): Jan. 26, 2026 at 5 p.m. Upon abstract acceptance, all posters must be uploaded and recorded on ...

Prof. Robert Sutton to deliver plenary presentation on Phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP) at American Pancreatic Association (APA) 2024 Annual Meeting Poster presentation on ...

VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 -- SYN-004 Interim blinded safety and pharmacokinetic data ...

MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

June 7, 2002 -- When interpreting results of clinical trials, doctors should beware of misleading data presentation, suggests an article in the June 5 issue of The Journal of the American Medical ...

VANCOUVER, BRITISH COLUMBIA, CANADA, July 30, 2025 /EINPresswire / -- ARC Medical Inc. , a clinical stage medical device company focused on advancing surgical adhesion prevention, today announced that ...

FORT MILL, S.C.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four ...

Shares of Sellas Life Sciences rose over 7% in premarket trading on Thursday as investors turned optimistic ahead of the ...